BANK OF AMERICA CORP /DE/
BankPosition in AGIO — Agios Pharmaceuticals, Inc.
CIK 70858
CHARLOTTE, NC
Position in AGIO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$18,847,016
+$1,664,762 QoQ
Shares Held
507,869
-0.0% QoQ
Ownership
0.851%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 238 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 38%
Shared 0%
None 62%
Common Shares in AGIO Over Time
Shares Held
Position Value (USD)
Derivatives in AGIO
reported options exposure · as of Jun 30, 2023CallValue
$849,600
CallShares
30,000
PutValue
$849,600
PutShares
30,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. AGIO ranks #89 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in AGIO
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,847,016 | 507,869 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $17,182,254 | 507,900 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $14,680,858 | 539,341 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $45,358,196 | 1,130,000 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $37,261,443 | 1,120,308 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $33,272,844 | 1,135,592 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $13,305,077 | 404,902 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $14,798,520 | 333,075 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $14,090,750 | 326,780 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $11,161,871 | 381,733 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $4,586,593 | 205,954 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $6,796,175 | 274,593 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $7,165,127 | 253,006 | Shares | Defined | 2023-08-14 | |
| 2023-06-30 | $849,600 | 30,000 | Call | Defined | 2023-08-14 | |
| 2023-06-30 | $849,600 | 30,000 | Put | Defined | 2023-08-14 | |
| 2023-03-31 | $682,209 | 29,700 | Call | Defined | 2023-05-12 | |
| 2023-03-31 | $682,209 | 29,700 | Put | Defined | 2023-05-12 | |
| 2023-03-31 | $9,726,230 | 423,432 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $7,398,263 | 263,471 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $8,014,464 | 283,397 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,595,106 | 162,161 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $7,776,355 | 267,137 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $9,275,255 | 282,180 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $6,297,671 | 136,461 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $9,154,650 | 166,116 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $7,759,630 | 150,264 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $5,914,498 | 136,499 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $5,656,805 | 161,623 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $9,155,237 | 171,190 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $8,919,882 | 251,406 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||